Novel motif:52: Difference between revisions
From FANTOM5_SSTAR
(Created page with "{{Novel_motif
|name=motif52_CGNATG
|novel_motifs_human_sample_pval=11376-118A8_11051;0.557715,11327-117E4_11969;0.394146,11473-119C6_11054;0.614176,11474-119C7_12067;0.42446...") |
No edit summary |
||
(3 intermediate revisions by the same user not shown) | |||
Line 1: | Line 1: | ||
{ | |||
Latest revision as of 14:47, 9 September 2013
name: | motif52_CGNATG |
---|
Association to promoter expression in human samples<b>Summary:</b>Significance of the correlation with CAGE expression, human <br><b>Analyst:</b> Michiel de Hoon<br><br>link to source dataset <br>data
Association to promoter expression in mouse samples
<b>Summary:</b>Significance of the correlation with CAGE expression, mouse <br><b>Analyst:</b> Michiel de Hoon<br><br>link to source dataset <br>data
GREAT analysis results for human
<b>Summary:</b>Genomic Enrichment of Annotations Tool (GREAT, Nat Biotechnol. 2010 May;28(5):495-501) is used to identify, both in human and in mouse, the gene ontology terms of biological processes enriched given the predicted TFBSs, and evaluated the overlap in the top-500 gene ontology terms between human and mouse. For each novel motif, the P value for the overlap was then evaluated by calculating its relative rank with respect to this background distribution.<br>Analyst: Michiel de Hoon<br><br>link to source dataset <br>data
GO ID | GO Term | p-value |
---|---|---|
GO:0042776 | mitochondrial ATP synthesis coupled proton transport | 1.640178e-9 |
GO:0032210 | regulation of telomere maintenance via telomerase | 4.459823e-8 |
GO:0016071 | mRNA metabolic process | 5.703862e-8 |
GO:0008033 | tRNA processing | 8.548451e-8 |
GO:0001955 | blood vessel maturation | 8.962616e-8 |
GO:0015986 | ATP synthesis coupled proton transport | 1.098908e-7 |
GO:0090072 | positive regulation of sodium ion transport via voltage-gated sodium channel activity | 1.179486e-7 |
GO:0006396 | RNA processing | 1.927207e-7 |
GO:0010310 | regulation of hydrogen peroxide metabolic process | 2.278258e-7 |
GO:0000956 | nuclear-transcribed mRNA catabolic process | 2.743615e-7 |
GO:0045922 | negative regulation of fatty acid metabolic process | 3.030502e-7 |
GO:0006414 | translational elongation | 3.469527e-7 |
GO:0008228 | opsonization | 3.988862e-7 |
GO:0050434 | positive regulation of viral transcription | 4.555007e-7 |
GO:0030967 | ER-nuclear sterol response pathway | 6.065494e-7 |
GO:0035522 | monoubiquitinated histone H2A deubiquitination | 6.819852e-7 |
GO:0045717 | negative regulation of fatty acid biosynthetic process | 1.240048e-6 |
GO:0000154 | rRNA modification | 1.393061e-6 |
GO:0032211 | negative regulation of telomere maintenance via telomerase | 1.861782e-6 |
GO:0034470 | ncRNA processing | 2.234242e-6 |
GO:0006391 | transcription initiation from mitochondrial promoter | 3.673458e-6 |
GO:0006402 | mRNA catabolic process | 4.797448e-6 |
GO:0045835 | negative regulation of meiosis | 4.823190e-6 |
GO:0071845 | cellular component disassembly at cellular level | 4.949213e-6 |
GO:0001842 | neural fold formation | 5.390803e-6 |
GO:0022411 | cellular component disassembly | 6.192169e-6 |
GO:0070245 | positive regulation of thymocyte apoptosis | 6.304913e-6 |
GO:0006401 | RNA catabolic process | 7.648540e-6 |
GO:0040020 | regulation of meiosis | 8.653468e-6 |
GO:0006412 | translation | 8.847979e-6 |
GO:0002418 | immune response to tumor cell | 8.950336e-6 |
GO:0046684 | response to pyrethroid | 8.956307e-6 |
GO:0016032 | viral reproduction | 9.917395e-6 |
GO:0006415 | translational termination | 1.051525e-5 |
GO:0008298 | intracellular mRNA localization | 1.180771e-5 |
GO:0031167 | rRNA methylation | 1.275125e-5 |
GO:0033081 | regulation of T cell differentiation in thymus | 1.289492e-5 |
GO:0007005 | mitochondrion organization | 1.371044e-5 |
GO:0042946 | glucoside transport | 1.436233e-5 |
GO:0070234 | positive regulation of T cell apoptosis | 1.480380e-5 |
GO:0001833 | inner cell mass cell proliferation | 2.351680e-5 |
GO:0060381 | positive regulation of single-stranded telomeric DNA binding | 2.678775e-5 |
GO:0070198 | protein localization to chromosome, telomeric region | 3.084998e-5 |
GO:0070243 | regulation of thymocyte apoptosis | 3.268657e-5 |
GO:0046782 | regulation of viral transcription | 3.402789e-5 |
GO:0022904 | respiratory electron transport chain | 3.536362e-5 |
GO:0033085 | negative regulation of T cell differentiation in thymus | 4.184334e-5 |
GO:0046037 | GMP metabolic process | 4.184334e-5 |
GO:0019264 | glycine biosynthetic process from serine | 4.198904e-5 |
GO:0000266 | mitochondrial fission | 4.221351e-5 |
GO:0071034 | CUT catabolic process | 4.286674e-5 |
GO:0051445 | regulation of meiotic cell cycle | 4.438770e-5 |
GO:0071169 | establishment of protein localization to chromatin | 5.181556e-5 |
GO:0000416 | positive regulation of histone H3-K36 methylation | 5.260952e-5 |
GO:0006383 | transcription from RNA polymerase III promoter | 5.578721e-5 |
GO:0090232 | positive regulation of spindle checkpoint | 5.607517e-5 |
GO:0043503 | skeletal muscle fiber adaptation | 6.061689e-5 |
GO:0006390 | transcription from mitochondrial promoter | 6.061689e-5 |
GO:0019083 | viral transcription | 6.914927e-5 |
GO:0060263 | regulation of respiratory burst | 8.543133e-5 |
GO:0006458 | 'de novo' protein folding | 9.088251e-5 |
GO:0042942 | D-serine transport | 9.103233e-5 |
GO:0051225 | spindle assembly | 9.225054e-5 |
GO:0000389 | nuclear mRNA 3'-splice site recognition | 9.267903e-5 |
GO:0051084 | 'de novo' posttranslational protein folding | 1.077586e-4 |
GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay | 1.091993e-4 |
GO:0001832 | blastocyst growth | 1.121335e-4 |
GO:0035928 | rRNA import into mitochondrion | 1.137507e-4 |
GO:0010642 | negative regulation of platelet-derived growth factor receptor signaling pathway | 1.156500e-4 |
GO:0010640 | regulation of platelet-derived growth factor receptor signaling pathway | 1.178298e-4 |
GO:0031124 | mRNA 3'-end processing | 1.190950e-4 |
GO:0009451 | RNA modification | 1.222059e-4 |
GO:0070230 | positive regulation of lymphocyte apoptosis | 1.251904e-4 |
GO:0051289 | protein homotetramerization | 1.415444e-4 |
GO:0045112 | integrin biosynthetic process | 1.429248e-4 |
GO:0045760 | positive regulation of action potential | 1.452232e-4 |
GO:0045218 | zonula adherens maintenance | 1.514114e-4 |
GO:0034661 | ncRNA catabolic process | 1.568966e-4 |
GO:0019087 | transformation of host cell by virus | 1.568966e-4 |
GO:0006354 | transcription elongation, DNA-dependent | 1.572729e-4 |
GO:0010609 | posttranscriptional regulation of gene expression by mRNA localization | 1.637025e-4 |
GO:0061157 | mRNA destabilization | 1.637025e-4 |
GO:0051089 | constitutive protein ectodomain proteolysis | 1.730263e-4 |
GO:0010266 | response to vitamin B1 | 1.730263e-4 |
GO:0000959 | mitochondrial RNA metabolic process | 1.733446e-4 |
GO:0002357 | defense response to tumor cell | 1.752285e-4 |
GO:0022613 | ribonucleoprotein complex biogenesis | 1.763463e-4 |
GO:2000660 | negative regulation of interleukin-1-mediated signaling pathway | 1.873261e-4 |
GO:0006368 | transcription elongation from RNA polymerase II promoter | 2.006569e-4 |
GO:0042770 | signal transduction in response to DNA damage | 2.008146e-4 |
GO:0006386 | termination of RNA polymerase III transcription | 2.027914e-4 |
GO:0006385 | transcription elongation from RNA polymerase III promoter | 2.027914e-4 |
GO:0060689 | cell differentiation involved in salivary gland development | 2.068270e-4 |
GO:0031123 | RNA 3'-end processing | 2.136082e-4 |
GO:0006457 | protein folding | 2.156809e-4 |
GO:0048168 | regulation of neuronal synaptic plasticity | 2.278552e-4 |
GO:0033233 | regulation of protein sumoylation | 2.323414e-4 |
GO:0070232 | regulation of T cell apoptosis | 2.360506e-4 |
GO:0015827 | tryptophan transport | 2.417173e-4 |
GO:0070228 | regulation of lymphocyte apoptosis | 2.689947e-4 |
GO:0045217 | cell-cell junction maintenance | 2.707974e-4 |
GO:0032793 | positive regulation of CREB transcription factor activity | 2.814608e-4 |
GO:0008611 | ether lipid biosynthetic process | 3.015042e-4 |
GO:0035461 | vitamin transmembrane transport | 3.041491e-4 |
GO:0048524 | positive regulation of viral reproduction | 3.193021e-4 |
GO:0051365 | cellular response to potassium ion starvation | 3.513238e-4 |
GO:0051081 | nuclear envelope disassembly | 3.514167e-4 |
GO:0034623 | cellular macromolecular complex disassembly | 3.527306e-4 |
GO:0048668 | collateral sprouting | 3.537101e-4 |
GO:0090231 | regulation of spindle checkpoint | 3.784238e-4 |
GO:0008286 | insulin receptor signaling pathway | 3.785178e-4 |
GO:0006400 | tRNA modification | 3.891626e-4 |
GO:0035095 | behavioral response to nicotine | 4.007119e-4 |
GO:0051590 | positive regulation of neurotransmitter transport | 4.237812e-4 |
GO:0071340 | skeletal muscle nicotinic acetylcholine receptor clustering | 4.290255e-4 |
GO:0034660 | ncRNA metabolic process | 4.471495e-4 |
GO:0071585 | detoxification of cadmium ion | 4.502267e-4 |
GO:0070946 | neutrophil mediated killing of gram-positive bacterium | 4.502267e-4 |
GO:0043382 | positive regulation of memory T cell differentiation | 4.603132e-4 |
GO:0032984 | macromolecular complex disassembly | 4.610007e-4 |
GO:0006119 | oxidative phosphorylation | 4.646743e-4 |
GO:0043624 | cellular protein complex disassembly | 4.725928e-4 |
GO:0072126 | positive regulation of glomerular mesangial cell proliferation | 5.033593e-4 |
GO:0071506 | cellular response to mycophenolic acid | 5.033593e-4 |
GO:0014912 | negative regulation of smooth muscle cell migration | 5.184273e-4 |
GO:0044236 | multicellular organismal metabolic process | 5.515005e-4 |
GO:0070212 | protein poly-ADP-ribosylation | 5.636869e-4 |
GO:0007007 | inner mitochondrial membrane organization | 5.666929e-4 |
GO:0006360 | transcription from RNA polymerase I promoter | 5.747366e-4 |
GO:0034445 | negative regulation of plasma lipoprotein particle oxidation | 5.778060e-4 |
GO:0009301 | snRNA transcription | 5.778060e-4 |
GO:0000492 | box C/D snoRNP assembly | 6.010537e-4 |
GO:0018026 | peptidyl-lysine monomethylation | 6.073757e-4 |
GO:0014819 | regulation of skeletal muscle contraction | 6.217813e-4 |
GO:0052697 | xenobiotic glucuronidation | 6.282530e-4 |
GO:0070980 | biphenyl catabolic process | 6.282530e-4 |
GO:0051552 | flavone metabolic process | 6.282530e-4 |
GO:0052696 | flavonoid glucuronidation | 6.282530e-4 |
GO:0006789 | bilirubin conjugation | 6.282530e-4 |
GO:0043241 | protein complex disassembly | 6.414156e-4 |
GO:0016075 | rRNA catabolic process | 6.500603e-4 |
GO:0045333 | cellular respiration | 6.723004e-4 |
GO:0014012 | peripheral nervous system axon regeneration | 6.734947e-4 |
GO:0000289 | nuclear-transcribed mRNA poly(A) tail shortening | 6.987916e-4 |
GO:0051344 | negative regulation of cyclic-nucleotide phosphodiesterase activity | 6.996202e-4 |
GO:0018158 | protein oxidation | 6.996202e-4 |
GO:0042723 | thiamine-containing compound metabolic process | 7.043000e-4 |
GO:0033084 | regulation of immature T cell proliferation in thymus | 7.079867e-4 |
GO:0070086 | ubiquitin-dependent endocytosis | 7.247696e-4 |
GO:0043000 | Golgi to plasma membrane CFTR protein transport | 7.247696e-4 |
GO:0071956 | cellular component maintenance at cellular level | 7.347625e-4 |
GO:0030262 | apoptotic nuclear change | 7.555288e-4 |
GO:0034502 | protein localization to chromosome | 7.642778e-4 |
GO:0018027 | peptidyl-lysine dimethylation | 7.745831e-4 |
GO:0015804 | neutral amino acid transport | 7.798484e-4 |
GO:0001956 | positive regulation of neurotransmitter secretion | 8.108614e-4 |
GO:0070253 | somatostatin secretion | 8.228816e-4 |
GO:0032812 | positive regulation of epinephrine secretion | 8.228816e-4 |
GO:0006571 | tyrosine biosynthetic process | 8.228816e-4 |
GO:0061003 | positive regulation of dendritic spine morphogenesis | 8.311852e-4 |
GO:0032259 | methylation | 8.338998e-4 |
GO:0071843 | cellular component biogenesis at cellular level | 8.530127e-4 |
GO:0051131 | chaperone-mediated protein complex assembly | 8.811093e-4 |
GO:0006423 | cysteinyl-tRNA aminoacylation | 8.888678e-4 |
GO:0016073 | snRNA metabolic process | 8.896498e-4 |
GO:0045657 | positive regulation of monocyte differentiation | 9.471197e-4 |
GO:0006370 | mRNA capping | 9.488803e-4 |
GO:0032204 | regulation of telomere maintenance | 9.681354e-4 |
GO:0022900 | electron transport chain | 1.011130e-3 |
GO:0007006 | mitochondrial membrane organization | 1.016111e-3 |
GO:0072303 | positive regulation of glomerular metanephric mesangial cell proliferation | 1.019710e-3 |
GO:0019047 | provirus integration | 1.038550e-3 |
GO:0016180 | snRNA processing | 1.070984e-3 |
GO:0033092 | positive regulation of immature T cell proliferation in thymus | 1.085966e-3 |
GO:0042118 | endothelial cell activation | 1.110522e-3 |
GO:0010902 | positive regulation of very-low-density lipoprotein particle remodeling | 1.134462e-3 |
GO:0060631 | regulation of meiosis I | 1.136127e-3 |
GO:0032205 | negative regulation of telomere maintenance | 1.160579e-3 |
GO:2000016 | negative regulation of determination of dorsal identity | 1.161155e-3 |
GO:0042998 | positive regulation of Golgi to plasma membrane protein transport | 1.161155e-3 |
GO:0045725 | positive regulation of glycogen biosynthetic process | 1.166992e-3 |
GO:0085020 | protein K6-linked ubiquitination | 1.200038e-3 |
GO:0051045 | negative regulation of membrane protein ectodomain proteolysis | 1.224568e-3 |
GO:0032206 | positive regulation of telomere maintenance | 1.226081e-3 |
GO:0003096 | renal sodium ion transport | 1.255300e-3 |
GO:0000288 | nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay | 1.260638e-3 |
GO:0014874 | response to stimulus involved in regulation of muscle adaptation | 1.277156e-3 |
GO:0045792 | negative regulation of cell size | 1.278086e-3 |
GO:0007035 | vacuolar acidification | 1.290864e-3 |
GO:0006839 | mitochondrial transport | 1.301673e-3 |
GO:0034080 | CenH3-containing nucleosome assembly at centromere | 1.307405e-3 |
GO:0033083 | regulation of immature T cell proliferation | 1.338661e-3 |
GO:0072668 | tubulin complex biogenesis | 1.444462e-3 |
GO:0046928 | regulation of neurotransmitter secretion | 1.450206e-3 |
GO:0030705 | cytoskeleton-dependent intracellular transport | 1.467968e-3 |
GO:0032506 | cytokinetic process | 1.475528e-3 |
GO:0043923 | positive regulation by host of viral transcription | 1.481140e-3 |
GO:0042254 | ribosome biogenesis | 1.486437e-3 |
GO:0090037 | positive regulation of protein kinase C signaling cascade | 1.502907e-3 |
GO:0014878 | response to electrical stimulus involved in regulation of muscle adaptation | 1.508729e-3 |
GO:2000243 | positive regulation of reproductive process | 1.544095e-3 |
GO:0030330 | DNA damage response, signal transduction by p53 class mediator | 1.633328e-3 |
GO:0034115 | negative regulation of heterotypic cell-cell adhesion | 1.689391e-3 |
GO:0035722 | interleukin-12-mediated signaling pathway | 1.698896e-3 |
GO:0046984 | regulation of hemoglobin biosynthetic process | 1.716379e-3 |
GO:0010430 | fatty acid omega-oxidation | 1.716379e-3 |
GO:0032148 | activation of protein kinase B activity | 1.717914e-3 |
GO:0008053 | mitochondrial fusion | 1.750026e-3 |
GO:0043508 | negative regulation of JUN kinase activity | 1.761777e-3 |
GO:0015780 | nucleotide-sugar transport | 1.812527e-3 |
GO:0043161 | proteasomal ubiquitin-dependent protein catabolic process | 1.816485e-3 |
GO:0000398 | nuclear mRNA splicing, via spliceosome | 1.852791e-3 |
GO:0007023 | post-chaperonin tubulin folding pathway | 1.855240e-3 |
GO:0090307 | spindle assembly involved in mitosis | 1.877254e-3 |
GO:0006907 | pinocytosis | 1.877254e-3 |
GO:0050720 | interleukin-1 beta biosynthetic process | 1.902739e-3 |
GO:0044265 | cellular macromolecule catabolic process | 1.940685e-3 |
GO:0070092 | regulation of glucagon secretion | 1.949498e-3 |
GO:0051029 | rRNA transport | 1.982676e-3 |
GO:0051937 | catecholamine transport | 2.017262e-3 |
GO:0072500 | negative regulation of transcription from RNA polymerase II promoter by nuclear hormone receptor | 2.079069e-3 |
GO:0032415 | regulation of sodium:hydrogen antiporter activity | 2.092839e-3 |
GO:0060029 | convergent extension involved in organogenesis | 2.130787e-3 |
GO:0046380 | N-acetylneuraminate biosynthetic process | 2.141930e-3 |
GO:0043456 | regulation of pentose-phosphate shunt | 2.141930e-3 |
GO:0016078 | tRNA catabolic process | 2.141930e-3 |
GO:0001682 | tRNA 5'-leader removal | 2.141930e-3 |
GO:0015728 | mevalonate transport | 2.157727e-3 |
GO:0060236 | regulation of mitotic spindle organization | 2.226693e-3 |
GO:0014056 | regulation of acetylcholine secretion | 2.227526e-3 |
GO:0071277 | cellular response to calcium ion | 2.240804e-3 |
GO:0045040 | protein import into mitochondrial outer membrane | 2.274521e-3 |
GO:0061014 | positive regulation of mRNA catabolic process | 2.275402e-3 |
GO:0002011 | morphogenesis of an epithelial sheet | 2.283579e-3 |
GO:0006397 | mRNA processing | 2.399066e-3 |
GO:0032717 | negative regulation of interleukin-8 production | 2.499754e-3 |
GO:0010970 | microtubule-based transport | 2.584692e-3 |
GO:0010498 | proteasomal protein catabolic process | 2.630683e-3 |
GO:0051571 | positive regulation of histone H3-K4 methylation | 2.661237e-3 |
GO:0034619 | cellular chaperone-mediated protein complex assembly | 2.673756e-3 |
GO:0072385 | minus-end-directed organelle transport along microtubule | 2.673756e-3 |
GO:2000015 | regulation of determination of dorsal identity | 2.734948e-3 |
GO:0071044 | histone mRNA catabolic process | 2.763558e-3 |
GO:0070213 | protein auto-ADP-ribosylation | 2.766177e-3 |
GO:0006399 | tRNA metabolic process | 2.771616e-3 |
GO:0006991 | response to sterol depletion | 2.807312e-3 |
GO:0031442 | positive regulation of mRNA 3'-end processing | 2.808677e-3 |
GO:0051531 | NFAT protein import into nucleus | 2.813051e-3 |
GO:0009452 | RNA capping | 2.894209e-3 |
GO:0033091 | positive regulation of immature T cell proliferation | 2.954074e-3 |
GO:0006526 | arginine biosynthetic process | 2.978821e-3 |
GO:0060112 | generation of ovulation cycle rhythm | 2.989184e-3 |
GO:0048549 | positive regulation of pinocytosis | 2.989184e-3 |
GO:0016559 | peroxisome fission | 2.989184e-3 |
GO:2000617 | positive regulation of histone H3-K9 acetylation | 3.035997e-3 |
GO:2000620 | positive regulation of histone H4-K16 acetylation | 3.035997e-3 |
GO:0070512 | positive regulation of histone H4-K20 methylation | 3.035997e-3 |
GO:0046986 | negative regulation of hemoglobin biosynthetic process | 3.035997e-3 |
GO:0045993 | negative regulation of translational initiation by iron | 3.035997e-3 |
GO:0060345 | spleen trabecula formation | 3.035997e-3 |
GO:0048560 | establishment of anatomical structure orientation | 3.042419e-3 |
GO:0032212 | positive regulation of telomere maintenance via telomerase | 3.063620e-3 |
GO:0044314 | protein K27-linked ubiquitination | 3.067914e-3 |
GO:0001988 | positive regulation of heart rate involved in baroreceptor response to decreased systemic arterial blood pressure | 3.067914e-3 |
GO:0035725 | sodium ion transmembrane transport | 3.080088e-3 |
GO:0042168 | heme metabolic process | 3.111023e-3 |
GO:0000414 | regulation of histone H3-K36 methylation | 3.142752e-3 |
GO:0001661 | conditioned taste aversion | 3.146298e-3 |
GO:0035767 | endothelial cell chemotaxis | 3.183480e-3 |
GO:0006564 | L-serine biosynthetic process | 3.199476e-3 |
GO:0014894 | response to denervation involved in regulation of muscle adaptation | 3.199476e-3 |
GO:0043084 | penile erection | 3.241295e-3 |
GO:0010823 | negative regulation of mitochondrion organization | 3.265213e-3 |
GO:0043653 | mitochondrial fragmentation involved in apoptosis | 3.459795e-3 |
GO:0044240 | multicellular organismal lipid catabolic process | 3.499873e-3 |
GO:0031055 | chromatin remodeling at centromere | 3.515610e-3 |
GO:0006376 | mRNA splice site selection | 3.572996e-3 |
GO:0032966 | negative regulation of collagen biosynthetic process | 3.588874e-3 |
GO:0022415 | viral reproductive process | 3.601187e-3 |
GO:0032456 | endocytic recycling | 3.632096e-3 |
GO:0010898 | positive regulation of triglyceride catabolic process | 3.635081e-3 |
GO:0060754 | positive regulation of mast cell chemotaxis | 3.721891e-3 |
GO:0048561 | establishment of organ orientation | 3.748275e-3 |
GO:0045663 | positive regulation of myoblast differentiation | 3.946723e-3 |
GO:0046485 | ether lipid metabolic process | 4.132184e-3 |
GO:0046498 | S-adenosylhomocysteine metabolic process | 4.164563e-3 |
GO:0072331 | signal transduction by p53 class mediator | 4.260411e-3 |
GO:0042775 | mitochondrial ATP synthesis coupled electron transport | 4.276298e-3 |
GO:0000920 | cytokinetic cell separation | 4.318425e-3 |
GO:0032329 | serine transport | 4.339146e-3 |
GO:0015817 | histidine transport | 4.356405e-3 |
GO:0032328 | alanine transport | 4.377110e-3 |
GO:0072110 | glomerular mesangial cell proliferation | 4.389769e-3 |
GO:0030512 | negative regulation of transforming growth factor beta receptor signaling pathway | 4.392627e-3 |
GO:0032869 | cellular response to insulin stimulus | 4.408734e-3 |
GO:0034378 | chylomicron assembly | 4.530192e-3 |
GO:0071934 | thiamine transmembrane transport | 4.530192e-3 |
GO:0045925 | positive regulation of female receptivity | 4.543216e-3 |
GO:0060450 | positive regulation of hindgut contraction | 4.543216e-3 |
GO:0042450 | arginine biosynthetic process via ornithine | 4.543216e-3 |
GO:0032469 | endoplasmic reticulum calcium ion homeostasis | 4.553878e-3 |
GO:0030433 | ER-associated protein catabolic process | 4.557325e-3 |
GO:0070671 | response to interleukin-12 | 4.648903e-3 |
GO:0048169 | regulation of long-term neuronal synaptic plasticity | 4.761701e-3 |
GO:0015844 | monoamine transport | 5.039147e-3 |
GO:0035344 | hypoxanthine transport | 5.042450e-3 |
GO:0035364 | thymine transport | 5.042450e-3 |
GO:0019303 | D-ribose catabolic process | 5.042450e-3 |
GO:0014809 | regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion | 5.042450e-3 |
GO:0015854 | guanine transport | 5.042450e-3 |
GO:0006051 | N-acetylmannosamine metabolic process | 5.042450e-3 |
GO:0000375 | RNA splicing, via transesterification reactions | 5.081000e-3 |
GO:0051096 | positive regulation of helicase activity | 5.134351e-3 |
GO:0009648 | photoperiodism | 5.134351e-3 |
GO:0051865 | protein autoubiquitination | 5.141352e-3 |
GO:0048790 | maintenance of presynaptic active zone structure | 5.142334e-3 |
GO:0035774 | positive regulation of insulin secretion involved in cellular response to glucose stimulus | 5.142334e-3 |
GO:0031630 | regulation of synaptic vesicle fusion to presynaptic membrane | 5.142334e-3 |
GO:0060340 | positive regulation of type I interferon-mediated signaling pathway | 5.182500e-3 |
GO:0044342 | type B pancreatic cell proliferation | 5.201615e-3 |
GO:0035883 | enteroendocrine cell differentiation | 5.201615e-3 |
GO:0010918 | positive regulation of mitochondrial membrane potential | 5.201615e-3 |
GO:0015808 | L-alanine transport | 5.218093e-3 |
GO:0019058 | viral infectious cycle | 5.259561e-3 |
GO:0006680 | glucosylceramide catabolic process | 5.329892e-3 |
GO:0010991 | negative regulation of SMAD protein complex assembly | 5.346599e-3 |
GO:0001510 | RNA methylation | 5.374215e-3 |
GO:0051569 | regulation of histone H3-K4 methylation | 5.392755e-3 |
GO:2000503 | positive regulation of natural killer cell chemotaxis | 5.515838e-3 |
GO:2000412 | positive regulation of thymocyte migration | 5.515838e-3 |
GO:2000518 | negative regulation of T-helper 1 cell activation | 5.515838e-3 |
GO:2000538 | positive regulation of B cell chemotaxis | 5.515838e-3 |
GO:0071663 | positive regulation of granzyme B production | 5.515838e-3 |
GO:2000513 | positive regulation of granzyme A production | 5.515838e-3 |
GO:0042941 | D-alanine transport | 5.515838e-3 |
GO:0033594 | response to hydroxyisoflavone | 5.515838e-3 |
GO:0035739 | CD4-positive, alpha-beta T cell proliferation | 5.515838e-3 |
GO:0035740 | CD8-positive, alpha-beta T cell proliferation | 5.515838e-3 |
GO:0035744 | T-helper 1 cell cytokine production | 5.515838e-3 |
GO:0043308 | eosinophil degranulation | 5.515838e-3 |
GO:0015992 | proton transport | 5.580135e-3 |
GO:2000318 | positive regulation of T-helper 17 type immune response | 5.710761e-3 |
GO:2000330 | positive regulation of T-helper 17 cell lineage commitment | 5.710761e-3 |
GO:0015824 | proline transport | 5.730297e-3 |
GO:0006921 | cellular component disassembly involved in apoptosis | 5.762005e-3 |
GO:0018126 | protein hydroxylation | 5.794361e-3 |
GO:0048149 | behavioral response to ethanol | 5.794361e-3 |
GO:0070574 | cadmium ion transmembrane transport | 5.891042e-3 |
GO:0090179 | planar cell polarity pathway involved in neural tube closure | 5.986811e-3 |
GO:0007018 | microtubule-based movement | 5.995965e-3 |
GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis | 6.275653e-3 |
GO:0006120 | mitochondrial electron transport, NADH to ubiquinone | 6.308836e-3 |
GO:0050685 | positive regulation of mRNA processing | 6.313225e-3 |
GO:0072384 | organelle transport along microtubule | 6.398948e-3 |
GO:0070925 | organelle assembly | 6.427516e-3 |
GO:0048548 | regulation of pinocytosis | 6.506045e-3 |
GO:0090275 | negative regulation of somatostatin secretion | 6.506045e-3 |
GO:0034442 | regulation of lipoprotein oxidation | 6.506045e-3 |
GO:0055090 | acylglycerol homeostasis | 6.551615e-3 |
GO:0032782 | bile acid secretion | 6.551615e-3 |
GO:0035871 | protein K11-linked deubiquitination | 6.551615e-3 |
GO:0008634 | negative regulation of survival gene product expression | 6.742131e-3 |
GO:0007128 | meiotic prophase I | 6.820479e-3 |
GO:0060338 | regulation of type I interferon-mediated signaling pathway | 6.857788e-3 |
GO:0044243 | multicellular organismal catabolic process | 6.915204e-3 |
GO:0051919 | positive regulation of fibrinolysis | 6.935898e-3 |
GO:0046853 | inositol or phosphatidylinositol phosphorylation | 6.935898e-3 |
GO:0009804 | coumarin metabolic process | 7.039732e-3 |
GO:0060267 | positive regulation of respiratory burst | 7.198060e-3 |
GO:0042772 | DNA damage response, signal transduction resulting in transcription | 7.330935e-3 |
GO:0070943 | neutrophil mediated killing of symbiont cell | 7.340279e-3 |
GO:0014051 | gamma-aminobutyric acid secretion | 7.340279e-3 |
GO:0007271 | synaptic transmission, cholinergic | 7.418851e-3 |
GO:0006361 | transcription initiation from RNA polymerase I promoter | 7.578991e-3 |
GO:0045292 | nuclear mRNA cis splicing, via spliceosome | 7.583083e-3 |
GO:0042503 | tyrosine phosphorylation of Stat3 protein | 7.583083e-3 |
GO:0048859 | formation of anatomical boundary | 7.782326e-3 |
GO:0045128 | negative regulation of reciprocal meiotic recombination | 7.833870e-3 |
GO:0006311 | meiotic gene conversion | 7.833870e-3 |
GO:0006867 | asparagine transport | 7.833870e-3 |
GO:0010820 | positive regulation of T cell chemotaxis | 7.934618e-3 |
GO:0031998 | regulation of fatty acid beta-oxidation | 7.942860e-3 |
GO:0006270 | DNA-dependent DNA replication initiation | 8.007036e-3 |
GO:0044258 | intestinal lipid catabolic process | 8.124580e-3 |
GO:0018350 | protein esterification | 8.124580e-3 |
GO:0006177 | GMP biosynthetic process | 8.124580e-3 |
GO:0007228 | positive regulation of hh target transcription factor activity | 8.124580e-3 |
GO:0006388 | tRNA splicing, via endonucleolytic cleavage and ligation | 8.124580e-3 |
GO:0010520 | regulation of reciprocal meiotic recombination | 8.163802e-3 |
GO:0002432 | granuloma formation | 8.163802e-3 |
GO:0060459 | left lung development | 8.211219e-3 |
GO:0000002 | mitochondrial genome maintenance | 8.218217e-3 |
GO:0042278 | purine nucleoside metabolic process | 8.249101e-3 |
GO:0032938 | negative regulation of translation in response to oxidative stress | 8.263551e-3 |
GO:0006797 | polyphosphate metabolic process | 8.263551e-3 |
GO:0006778 | porphyrin-containing compound metabolic process | 8.296861e-3 |
GO:0050779 | RNA destabilization | 8.402104e-3 |
GO:0009303 | rRNA transcription | 8.481656e-3 |
GO:0070875 | positive regulation of glycogen metabolic process | 8.524534e-3 |
GO:0006818 | hydrogen transport | 8.555297e-3 |
GO:0006978 | DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator | 8.614604e-3 |
GO:0001514 | selenocysteine incorporation | 8.639114e-3 |
GO:0060071 | Wnt receptor signaling pathway, planar cell polarity pathway | 8.681519e-3 |
GO:0031440 | regulation of mRNA 3'-end processing | 8.681519e-3 |
GO:0045581 | negative regulation of T cell differentiation | 8.821539e-3 |
GO:0043414 | macromolecule methylation | 8.932231e-3 |
GO:0014888 | striated muscle adaptation | 8.949637e-3 |
GO:0035519 | protein K29-linked ubiquitination | 8.957146e-3 |
GO:0051256 | spindle midzone assembly involved in mitosis | 8.957146e-3 |
GO:0022007 | convergent extension involved in neural plate elongation | 8.957146e-3 |
GO:0031558 | induction of apoptosis in response to chemical stimulus | 8.993277e-3 |
GO:0070926 | regulation of ATP:ADP antiporter activity | 9.154691e-3 |
GO:0033194 | response to hydroperoxide | 9.200788e-3 |
GO:0032042 | mitochondrial DNA metabolic process | 9.207775e-3 |
GO:0006334 | nucleosome assembly | 9.524380e-3 |
GO:0008334 | histone mRNA metabolic process | 9.559709e-3 |
GO:0060319 | primitive erythrocyte differentiation | 9.594703e-3 |
GO:0002575 | basophil chemotaxis | 9.594703e-3 |
GO:0000710 | meiotic mismatch repair | 9.597670e-3 |
GO:0014057 | positive regulation of acetylcholine secretion | 9.597670e-3 |
GO:0018022 | peptidyl-lysine methylation | 9.739676e-3 |
GO:0060662 | salivary gland cavitation | 9.898100e-3 |
GO:0033572 | transferrin transport | 9.923701e-3 |
GO:0051085 | chaperone mediated protein folding requiring cofactor | 1.007328e-2 |
GO:0033235 | positive regulation of protein sumoylation | 1.007328e-2 |
GO:0002579 | positive regulation of antigen processing and presentation | 1.018868e-2 |
GO:0005979 | regulation of glycogen biosynthetic process | 1.039132e-2 |
GO:0032091 | negative regulation of protein binding | 1.051846e-2 |
GO:0032471 | reduction of endoplasmic reticulum calcium ion concentration | 1.054611e-2 |
GO:0015939 | pantothenate metabolic process | 1.065550e-2 |
GO:0060213 | positive regulation of nuclear-transcribed mRNA poly(A) tail shortening | 1.067442e-2 |
GO:0071777 | positive regulation of cell cycle cytokinesis | 1.068160e-2 |
GO:0001867 | complement activation, lectin pathway | 1.068160e-2 |
GO:0035372 | protein localization to microtubule | 1.083286e-2 |
GO:0040032 | post-embryonic body morphogenesis | 1.089795e-2 |
GO:0001978 | regulation of systemic arterial blood pressure by carotid sinus baroreceptor feedback | 1.092979e-2 |
GO:0031448 | positive regulation of fast-twitch skeletal muscle fiber contraction | 1.120705e-2 |
GO:0002003 | angiotensin maturation | 1.120705e-2 |
GO:0071421 | manganese ion transmembrane transport | 1.149766e-2 |
GO:0006285 | base-excision repair, AP site formation | 1.149766e-2 |
GO:0071584 | negative regulation of zinc ion import | 1.154083e-2 |
GO:0090281 | negative regulation of calcium ion import | 1.154083e-2 |
GO:0051791 | medium-chain fatty acid metabolic process | 1.154083e-2 |
GO:0034721 | histone H3-K4 demethylation, trimethyl-H3-K4-specific | 1.154083e-2 |
GO:0051343 | positive regulation of cyclic-nucleotide phosphodiesterase activity | 1.154083e-2 |
GO:0033490 | cholesterol biosynthetic process via lathosterol | 1.154083e-2 |
GO:0006741 | NADP biosynthetic process | 1.154083e-2 |
GO:0043486 | histone exchange | 1.160816e-2 |
GO:0035520 | monoubiquitinated protein deubiquitination | 1.161745e-2 |
GO:0043928 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 1.168004e-2 |
GO:0010172 | embryonic body morphogenesis | 1.182721e-2 |
GO:0046365 | monosaccharide catabolic process | 1.190565e-2 |
GO:0021535 | cell migration in hindbrain | 1.195880e-2 |
GO:0051006 | positive regulation of lipoprotein lipase activity | 1.203260e-2 |
GO:0001835 | blastocyst hatching | 1.203260e-2 |
GO:0006363 | termination of RNA polymerase I transcription | 1.214280e-2 |
GO:0006471 | protein ADP-ribosylation | 1.214525e-2 |
GO:0051461 | positive regulation of corticotropin secretion | 1.231334e-2 |
GO:0071460 | cellular response to cell-matrix adhesion | 1.231334e-2 |
GO:0031638 | zymogen activation | 1.231334e-2 |
GO:0071042 | nuclear polyadenylation-dependent mRNA catabolic process | 1.237200e-2 |
GO:2000627 | positive regulation of miRNA catabolic process | 1.237200e-2 |
GO:0000964 | mitochondrial RNA 5'-end processing | 1.237200e-2 |
GO:0060847 | endothelial cell fate specification | 1.261095e-2 |
GO:0090201 | negative regulation of release of cytochrome c from mitochondria | 1.263331e-2 |
GO:0030505 | inorganic diphosphate transport | 1.263331e-2 |
GO:0000726 | non-recombinational repair | 1.287167e-2 |
GO:0007608 | sensory perception of smell | 1.292960e-2 |
GO:0006957 | complement activation, alternative pathway | 1.294266e-2 |
GO:0033119 | negative regulation of RNA splicing | 1.297960e-2 |
GO:0042506 | tyrosine phosphorylation of Stat5 protein | 1.300582e-2 |
GO:0006260 | DNA replication | 1.303859e-2 |
GO:0016446 | somatic hypermutation of immunoglobulin genes | 1.307719e-2 |
GO:0045626 | negative regulation of T-helper 1 cell differentiation | 1.315708e-2 |
GO:0032963 | collagen metabolic process | 1.316734e-2 |
GO:0035881 | amacrine cell differentiation | 1.321531e-2 |
GO:0070094 | positive regulation of glucagon secretion | 1.321531e-2 |
GO:0023021 | termination of signal transduction | 1.321531e-2 |
GO:0006984 | ER-nucleus signaling pathway | 1.332243e-2 |
GO:0070407 | oxidation-dependent protein catabolic process | 1.353344e-2 |
GO:0009399 | nitrogen fixation | 1.353344e-2 |
GO:0032185 | septin cytoskeleton organization | 1.367766e-2 |
GO:0032435 | negative regulation of proteasomal ubiquitin-dependent protein catabolic process | 1.388360e-2 |
GO:0032417 | positive regulation of sodium:hydrogen antiporter activity | 1.395211e-2 |
GO:0009785 | blue light signaling pathway | 1.395211e-2 |
GO:0006626 | protein targeting to mitochondrion | 1.417606e-2 |
GO:0048167 | regulation of synaptic plasticity | 1.421952e-2 |
GO:0006309 | DNA fragmentation involved in apoptotic nuclear change | 1.425633e-2 |
GO:0008617 | guanosine metabolic process | 1.430472e-2 |
GO:0035313 | wound healing, spreading of epidermal cells | 1.437639e-2 |
GO:0007021 | tubulin complex assembly | 1.442978e-2 |
GO:0016072 | rRNA metabolic process | 1.453958e-2 |
GO:0072109 | glomerular mesangium development | 1.466409e-2 |
GO:0051255 | spindle midzone assembly | 1.485329e-2 |
GO:0034728 | nucleosome organization | 1.486663e-2 |
GO:0032964 | collagen biosynthetic process | 1.489593e-2 |
GO:0045655 | regulation of monocyte differentiation | 1.495028e-2 |
GO:0010713 | negative regulation of collagen metabolic process | 1.495869e-2 |
GO:0033013 | tetrapyrrole metabolic process | 1.499373e-2 |
GO:0032933 | SREBP-mediated signaling pathway | 1.506359e-2 |
GREAT analysis results for mouseGenomic Enrichment of Annotations Tool (GREAT, Nat Biotechnol. 2010 May;28(5):495-501) is used to identify, both in human and in mouse, the gene ontology terms of biological processes enriched given the predicted TFBSs, and evaluated the overlap in the top-500 gene ontology terms between human and mouse. For each novel motif, the P value for the overlap was then evaluated by calculating its relative rank with respect to this background distribution.<br>Analyst: Michiel de Hoon <br><br>link to source dataset <br>data
GO ID | GO Term | p-value |
---|---|---|
GO:0010896 | regulation of triglyceride catabolic process | 6.841858e-13 |
GO:0090207 | regulation of triglyceride metabolic process | 3.013321e-12 |
GO:0051004 | regulation of lipoprotein lipase activity | 6.116549e-12 |
GO:0048597 | post-embryonic camera-type eye morphogenesis | 5.824441e-10 |
GO:0051006 | positive regulation of lipoprotein lipase activity | 1.536710e-9 |
GO:0048050 | post-embryonic eye morphogenesis | 2.227322e-9 |
GO:0006982 | response to lipid hydroperoxide | 7.963287e-9 |
GO:0002352 | B cell negative selection | 1.176622e-8 |
GO:0002227 | innate immune response in mucosa | 1.695810e-8 |
GO:0050748 | negative regulation of lipoprotein metabolic process | 1.990205e-8 |
GO:0010898 | positive regulation of triglyceride catabolic process | 2.222812e-8 |
GO:0010901 | regulation of very-low-density lipoprotein particle remodeling | 3.807490e-8 |
GO:0010902 | positive regulation of very-low-density lipoprotein particle remodeling | 3.839538e-8 |
GO:0006412 | translation | 3.870907e-8 |
GO:0034445 | negative regulation of plasma lipoprotein particle oxidation | 4.755680e-8 |
GO:0006403 | RNA localization | 5.381008e-8 |
GO:0050658 | RNA transport | 1.025947e-7 |
GO:0060029 | convergent extension involved in organogenesis | 1.105753e-7 |
GO:0034442 | regulation of lipoprotein oxidation | 1.238254e-7 |
GO:0051028 | mRNA transport | 1.249872e-7 |
GO:0010873 | positive regulation of cholesterol esterification | 1.516369e-7 |
GO:0042157 | lipoprotein metabolic process | 1.524868e-7 |
GO:0044240 | multicellular organismal lipid catabolic process | 2.245402e-7 |
GO:0090209 | negative regulation of triglyceride metabolic process | 3.182092e-7 |
GO:0050746 | regulation of lipoprotein metabolic process | 3.531859e-7 |
GO:0022007 | convergent extension involved in neural plate elongation | 3.685388e-7 |
GO:0030300 | regulation of intestinal cholesterol absorption | 4.298351e-7 |
GO:0034369 | plasma lipoprotein particle remodeling | 8.841373e-7 |
GO:0010872 | regulation of cholesterol esterification | 9.211395e-7 |
GO:0060338 | regulation of type I interferon-mediated signaling pathway | 1.199006e-6 |
GO:0090084 | negative regulation of inclusion body assembly | 1.781979e-6 |
GO:0090179 | planar cell polarity pathway involved in neural tube closure | 1.931936e-6 |
GO:0010332 | response to gamma radiation | 2.140350e-6 |
GO:0031330 | negative regulation of cellular catabolic process | 2.156841e-6 |
GO:0007256 | activation of JNKK activity | 2.174608e-6 |
GO:0006260 | DNA replication | 2.619500e-6 |
GO:0034441 | plasma lipoprotein particle oxidation | 2.968414e-6 |
GO:0055090 | acylglycerol homeostasis | 3.490566e-6 |
GO:0006413 | translational initiation | 3.694704e-6 |
GO:0043457 | regulation of cellular respiration | 4.401975e-6 |
GO:0090086 | negative regulation of protein deubiquitination | 4.672813e-6 |
GO:0045767 | regulation of anti-apoptosis | 4.979234e-6 |
GO:0015931 | nucleobase-containing compound transport | 6.108161e-6 |
GO:0010987 | negative regulation of high-density lipoprotein particle clearance | 6.791478e-6 |
GO:0010897 | negative regulation of triglyceride catabolic process | 6.791478e-6 |
GO:0043030 | regulation of macrophage activation | 8.350251e-6 |
GO:2000286 | receptor internalization involved in canonical Wnt receptor signaling pathway | 8.649244e-6 |
GO:0050706 | regulation of interleukin-1 beta secretion | 8.890523e-6 |
GO:0001777 | T cell homeostatic proliferation | 9.337393e-6 |
GO:0014878 | response to electrical stimulus involved in regulation of muscle adaptation | 1.100670e-5 |
GO:0033344 | cholesterol efflux | 1.117589e-5 |
GO:0006283 | transcription-coupled nucleotide-excision repair | 1.162098e-5 |
GO:0006364 | rRNA processing | 1.252165e-5 |
GO:0033700 | phospholipid efflux | 1.346799e-5 |
GO:0051005 | negative regulation of lipoprotein lipase activity | 1.494444e-5 |
GO:0016973 | poly(A)+ mRNA export from nucleus | 1.642741e-5 |
GO:0010982 | regulation of high-density lipoprotein particle clearance | 1.642741e-5 |
GO:0032435 | negative regulation of proteasomal ubiquitin-dependent protein catabolic process | 1.894546e-5 |
GO:0043928 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 1.982659e-5 |
GO:0043032 | positive regulation of macrophage activation | 2.139656e-5 |
GO:0032717 | negative regulation of interleukin-8 production | 2.150434e-5 |
GO:0016072 | rRNA metabolic process | 2.358679e-5 |
GO:0060071 | Wnt receptor signaling pathway, planar cell polarity pathway | 2.439653e-5 |
GO:0090208 | positive regulation of triglyceride metabolic process | 2.661678e-5 |
GO:0050704 | regulation of interleukin-1 secretion | 2.784019e-5 |
GO:0044058 | regulation of digestive system process | 3.724180e-5 |
GO:0032792 | negative regulation of CREB transcription factor activity | 3.761118e-5 |
GO:0045861 | negative regulation of proteolysis | 3.767200e-5 |
GO:0006338 | chromatin remodeling | 3.944053e-5 |
GO:0002011 | morphogenesis of an epithelial sheet | 4.156389e-5 |
GO:0060191 | regulation of lipase activity | 4.276384e-5 |
GO:0070059 | apoptosis in response to endoplasmic reticulum stress | 4.418105e-5 |
GO:0032651 | regulation of interleukin-1 beta production | 4.831858e-5 |
GO:0002339 | B cell selection | 4.925535e-5 |
GO:0070328 | triglyceride homeostasis | 5.198584e-5 |
GO:0010916 | negative regulation of very-low-density lipoprotein particle clearance | 5.583376e-5 |
GO:0070079 | histone H4-R3 demethylation | 5.684479e-5 |
GO:2000016 | negative regulation of determination of dorsal identity | 5.684479e-5 |
GO:0070078 | histone H3-R2 demethylation | 5.684479e-5 |
GO:0046607 | positive regulation of centrosome cycle | 5.684479e-5 |
GO:0018395 | peptidyl-lysine hydroxylation to 5-hydroxy-L-lysine | 5.684479e-5 |
GO:0048633 | positive regulation of skeletal muscle tissue growth | 5.684479e-5 |
GO:0046604 | positive regulation of mitotic centrosome separation | 6.043152e-5 |
GO:0043691 | reverse cholesterol transport | 6.440004e-5 |
GO:0007008 | outer mitochondrial membrane organization | 6.707382e-5 |
GO:0010960 | magnesium ion homeostasis | 6.961434e-5 |
GO:0046853 | inositol or phosphatidylinositol phosphorylation | 7.039421e-5 |
GO:0071340 | skeletal muscle nicotinic acetylcholine receptor clustering | 7.166937e-5 |
GO:0050994 | regulation of lipid catabolic process | 7.256199e-5 |
GO:0042304 | regulation of fatty acid biosynthetic process | 7.314138e-5 |
GO:0032471 | reduction of endoplasmic reticulum calcium ion concentration | 8.006268e-5 |
GO:0002385 | mucosal immune response | 1.070113e-4 |
GO:0001835 | blastocyst hatching | 1.074739e-4 |
GO:0061034 | olfactory bulb mitral cell layer development | 1.074739e-4 |
GO:0070836 | caveola assembly | 1.107885e-4 |
GO:0003323 | type B pancreatic cell development | 1.118147e-4 |
GO:0006281 | DNA repair | 1.133770e-4 |
GO:0001959 | regulation of cytokine-mediated signaling pathway | 1.156456e-4 |
GO:0046985 | positive regulation of hemoglobin biosynthetic process | 1.210501e-4 |
GO:0043973 | histone H3-K4 acetylation | 1.210501e-4 |
GO:0000972 | transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery | 1.210501e-4 |
GO:0030264 | nuclear fragmentation involved in apoptotic nuclear change | 1.210501e-4 |
GO:0006994 | positive regulation of transcription via sterol regulatory element binding involved in ER-nuclear sterol response pathway | 1.210501e-4 |
GO:0034382 | chylomicron remnant clearance | 1.287599e-4 |
GO:2000384 | negative regulation of ectoderm development | 1.371496e-4 |
GO:0032652 | regulation of interleukin-1 production | 1.388109e-4 |
GO:0031440 | regulation of mRNA 3'-end processing | 1.398582e-4 |
GO:0032434 | regulation of proteasomal ubiquitin-dependent protein catabolic process | 1.423707e-4 |
GO:0010989 | negative regulation of low-density lipoprotein particle clearance | 1.427390e-4 |
GO:0007049 | cell cycle | 1.450971e-4 |
GO:0042254 | ribosome biogenesis | 1.454930e-4 |
GO:0033137 | negative regulation of peptidyl-serine phosphorylation | 1.505896e-4 |
GO:0035234 | germ cell programmed cell death | 1.695364e-4 |
GO:0006290 | pyrimidine dimer repair | 1.695364e-4 |
GO:0006678 | glucosylceramide metabolic process | 1.695364e-4 |
GO:0060759 | regulation of response to cytokine stimulus | 1.698274e-4 |
GO:0033484 | nitric oxide homeostasis | 1.705235e-4 |
GO:0009299 | mRNA transcription | 1.705235e-4 |
GO:0009296 | flagellum assembly | 1.714730e-4 |
GO:0034660 | ncRNA metabolic process | 1.755970e-4 |
GO:0071843 | cellular component biogenesis at cellular level | 1.880026e-4 |
GO:0002251 | organ or tissue specific immune response | 1.906455e-4 |
GO:0071169 | establishment of protein localization to chromatin | 1.935946e-4 |
GO:0006427 | histidyl-tRNA aminoacylation | 1.935946e-4 |
GO:0043064 | flagellum organization | 1.968048e-4 |
GO:0006259 | DNA metabolic process | 1.987584e-4 |
GO:0048668 | collateral sprouting | 2.010864e-4 |
GO:0042789 | mRNA transcription from RNA polymerase II promoter | 2.047136e-4 |
GO:0031442 | positive regulation of mRNA 3'-end processing | 2.097147e-4 |
GO:0034470 | ncRNA processing | 2.119373e-4 |
GO:0043666 | regulation of phosphoprotein phosphatase activity | 2.145624e-4 |
GO:0051168 | nuclear export | 2.160799e-4 |
GO:0006284 | base-excision repair | 2.219649e-4 |
GO:0010225 | response to UV-C | 2.386507e-4 |
GO:0001736 | establishment of planar polarity | 2.430930e-4 |
GO:0007007 | inner mitochondrial membrane organization | 2.510720e-4 |
GO:0022613 | ribonucleoprotein complex biogenesis | 2.535040e-4 |
GO:0060213 | positive regulation of nuclear-transcribed mRNA poly(A) tail shortening | 2.559127e-4 |
GO:0010985 | negative regulation of lipoprotein particle clearance | 2.574486e-4 |
GO:0009059 | macromolecule biosynthetic process | 2.771684e-4 |
GO:0031113 | regulation of microtubule polymerization | 2.819576e-4 |
GO:0034645 | cellular macromolecule biosynthetic process | 2.823266e-4 |
GO:0044260 | cellular macromolecule metabolic process | 2.845108e-4 |
GO:0060192 | negative regulation of lipase activity | 3.052038e-4 |
GO:0007080 | mitotic metaphase plate congression | 3.106242e-4 |
GO:0071354 | cellular response to interleukin-6 | 3.107378e-4 |
GO:0009154 | purine ribonucleotide catabolic process | 3.244684e-4 |
GO:0015991 | ATP hydrolysis coupled proton transport | 3.279500e-4 |
GO:0045428 | regulation of nitric oxide biosynthetic process | 3.290124e-4 |
GO:0072201 | negative regulation of mesenchymal cell proliferation | 3.379899e-4 |
GO:0051402 | neuron apoptosis | 3.428817e-4 |
GO:0019433 | triglyceride catabolic process | 3.469763e-4 |
GO:0045585 | positive regulation of cytotoxic T cell differentiation | 3.500040e-4 |
GO:0060026 | convergent extension | 3.504326e-4 |
GO:0007006 | mitochondrial membrane organization | 3.611727e-4 |
GO:0010984 | regulation of lipoprotein particle clearance | 3.742219e-4 |
GO:0006808 | regulation of nitrogen utilization | 3.773550e-4 |
GO:2000383 | regulation of ectoderm development | 3.882883e-4 |
GO:0090085 | regulation of protein deubiquitination | 3.882883e-4 |
GO:0042662 | negative regulation of mesodermal cell fate specification | 3.882883e-4 |
GO:0009895 | negative regulation of catabolic process | 3.918192e-4 |
GO:0009261 | ribonucleotide catabolic process | 4.017993e-4 |
GO:0071679 | commissural neuron axon guidance | 4.052351e-4 |
GO:0021860 | pyramidal neuron development | 4.201540e-4 |
GO:0006406 | mRNA export from nucleus | 4.277901e-4 |
GO:0002262 | myeloid cell homeostasis | 4.441606e-4 |
GO:0032269 | negative regulation of cellular protein metabolic process | 4.680541e-4 |
GO:0031116 | positive regulation of microtubule polymerization | 4.701784e-4 |
GO:0042998 | positive regulation of Golgi to plasma membrane protein transport | 4.726421e-4 |
GO:0045836 | positive regulation of meiosis | 4.818043e-4 |
GO:0002418 | immune response to tumor cell | 4.959332e-4 |
GO:0071827 | plasma lipoprotein particle organization | 5.076333e-4 |
GO:0043249 | erythrocyte maturation | 5.201206e-4 |
GO:0009207 | purine ribonucleoside triphosphate catabolic process | 5.223454e-4 |
GO:0046666 | retinal cell programmed cell death | 5.273217e-4 |
GO:0007616 | long-term memory | 5.320117e-4 |
GO:0001839 | neural plate morphogenesis | 5.396481e-4 |
GO:0010212 | response to ionizing radiation | 5.513703e-4 |
GO:0060058 | positive regulation of apoptosis involved in mammary gland involution | 5.519803e-4 |
GO:0090177 | establishment of planar polarity involved in neural tube closure | 5.674783e-4 |
GO:0000492 | box C/D snoRNP assembly | 5.674783e-4 |
GO:0060296 | regulation of cilium beat frequency involved in ciliary motility | 5.822367e-4 |
GO:0043968 | histone H2A acetylation | 5.873228e-4 |
GO:0021756 | striatum development | 5.984353e-4 |
GO:0046587 | positive regulation of calcium-dependent cell-cell adhesion | 6.007034e-4 |
GO:0043148 | mitotic spindle stabilization | 6.007034e-4 |
GO:0034349 | glial cell apoptosis | 6.148207e-4 |
GO:0006974 | response to DNA damage stimulus | 6.158365e-4 |
GO:0060068 | vagina development | 6.167343e-4 |
GO:0070507 | regulation of microtubule cytoskeleton organization | 6.170834e-4 |
GO:0007164 | establishment of tissue polarity | 6.238860e-4 |
GO:0050995 | negative regulation of lipid catabolic process | 6.387140e-4 |
GO:0048563 | post-embryonic organ morphogenesis | 6.712861e-4 |
GO:0044237 | cellular metabolic process | 6.802328e-4 |
GO:0060913 | cardiac cell fate determination | 7.338834e-4 |
GO:0060028 | convergent extension involved in axis elongation | 7.338834e-4 |
GO:0043558 | regulation of translational initiation in response to stress | 7.338834e-4 |
GO:0006641 | triglyceride metabolic process | 7.400742e-4 |
GO:0031331 | positive regulation of cellular catabolic process | 7.547966e-4 |
GO:0009146 | purine nucleoside triphosphate catabolic process | 7.550419e-4 |
GO:0060712 | spongiotrophoblast layer development | 7.625252e-4 |
GO:0045768 | positive regulation of anti-apoptosis | 7.721415e-4 |
GO:0060621 | negative regulation of cholesterol import | 7.910230e-4 |
GO:0045019 | negative regulation of nitric oxide biosynthetic process | 7.910230e-4 |
GO:0032374 | regulation of cholesterol transport | 7.951183e-4 |
GO:0072523 | purine-containing compound catabolic process | 8.140272e-4 |
GO:0006405 | RNA export from nucleus | 8.385891e-4 |
GO:0000726 | non-recombinational repair | 8.493265e-4 |
GO:0065005 | protein-lipid complex assembly | 8.760480e-4 |
GO:0046356 | acetyl-CoA catabolic process | 9.227064e-4 |
GO:0015876 | acetyl-CoA transport | 9.738579e-4 |
GO:0006597 | spermine biosynthetic process | 9.738579e-4 |
GO:0042273 | ribosomal large subunit biogenesis | 9.756086e-4 |
GO:0050713 | negative regulation of interleukin-1 beta secretion | 9.771852e-4 |
GO:0042633 | hair cycle | 9.890194e-4 |
GO:0006398 | histone mRNA 3'-end processing | 1.001847e-3 |
GO:0035752 | lysosomal lumen pH elevation | 1.019361e-3 |
GO:0045626 | negative regulation of T-helper 1 cell differentiation | 1.019361e-3 |
GO:0001575 | globoside metabolic process | 1.019361e-3 |
GO:0000046 | autophagic vacuole fusion | 1.019361e-3 |
GO:0006677 | glycosylceramide metabolic process | 1.028957e-3 |
GO:0001539 | ciliary or flagellar motility | 1.028957e-3 |
GO:0046724 | oxalic acid secretion | 1.059481e-3 |
GO:0043048 | dolichyl monophosphate biosynthetic process | 1.059481e-3 |
GO:0019265 | glycine biosynthetic process, by transamination of glyoxylate | 1.059481e-3 |
GO:0035356 | cellular triglyceride homeostasis | 1.059481e-3 |
GO:0009586 | rhodopsin mediated phototransduction | 1.081432e-3 |
GO:0018298 | protein-chromophore linkage | 1.119410e-3 |
GO:0051705 | behavioral interaction between organisms | 1.129258e-3 |
GO:0033599 | regulation of mammary gland epithelial cell proliferation | 1.159221e-3 |
GO:0046464 | acylglycerol catabolic process | 1.229883e-3 |
GO:0009143 | nucleoside triphosphate catabolic process | 1.251662e-3 |
GO:0060271 | cilium morphogenesis | 1.289162e-3 |
GO:0033135 | regulation of peptidyl-serine phosphorylation | 1.339627e-3 |
GO:0042536 | negative regulation of tumor necrosis factor biosynthetic process | 1.343836e-3 |
GO:0060975 | cardioblast migration to the midline involved in heart field formation | 1.366936e-3 |
GO:0045090 | retroviral genome replication | 1.366936e-3 |
GO:2000429 | negative regulation of neutrophil aggregation | 1.366936e-3 |
GO:2000469 | negative regulation of peroxidase activity | 1.366936e-3 |
GO:0042942 | D-serine transport | 1.366936e-3 |
GO:0071638 | negative regulation of monocyte chemotactic protein-1 production | 1.366936e-3 |
GO:0035481 | positive regulation of Notch signaling pathway involved in heart induction | 1.366936e-3 |
GO:0002357 | defense response to tumor cell | 1.366936e-3 |
GO:0003210 | cardiac atrium formation | 1.366936e-3 |
GO:0003236 | sinus venosus morphogenesis | 1.366936e-3 |
GO:0035726 | common myeloid progenitor cell proliferation | 1.366936e-3 |
GO:0003259 | cardioblast anterior-lateral migration | 1.366936e-3 |
GO:0061136 | regulation of proteasomal protein catabolic process | 1.392263e-3 |
GO:0016480 | negative regulation of transcription from RNA polymerase III promoter | 1.394093e-3 |
GO:0035810 | positive regulation of urine volume | 1.438782e-3 |
GO:0009109 | coenzyme catabolic process | 1.447936e-3 |
GO:0090026 | positive regulation of monocyte chemotaxis | 1.460266e-3 |
GO:0031112 | positive regulation of microtubule polymerization or depolymerization | 1.488445e-3 |
GO:0006310 | DNA recombination | 1.502601e-3 |
GO:0050718 | positive regulation of interleukin-1 beta secretion | 1.524671e-3 |
GO:0001942 | hair follicle development | 1.540241e-3 |
GO:0006396 | RNA processing | 1.571610e-3 |
GO:0006391 | transcription initiation from mitochondrial promoter | 1.630346e-3 |
GO:0043031 | negative regulation of macrophage activation | 1.630346e-3 |
GO:0042059 | negative regulation of epidermal growth factor receptor signaling pathway | 1.690084e-3 |
GO:0000186 | activation of MAPKK activity | 1.726430e-3 |
GO:0060620 | regulation of cholesterol import | 1.767574e-3 |
GO:0090083 | regulation of inclusion body assembly | 1.767574e-3 |
GO:0042664 | negative regulation of endodermal cell fate specification | 1.784098e-3 |
GO:0071480 | cellular response to gamma radiation | 1.817464e-3 |
GO:0060560 | developmental growth involved in morphogenesis | 1.838518e-3 |
GO:0048631 | regulation of skeletal muscle tissue growth | 1.898020e-3 |
GO:0046984 | regulation of hemoglobin biosynthetic process | 1.905678e-3 |
GO:0045940 | positive regulation of steroid metabolic process | 1.910303e-3 |
GO:0045625 | regulation of T-helper 1 cell differentiation | 1.954447e-3 |
GO:0034372 | very-low-density lipoprotein particle remodeling | 1.973374e-3 |
GO:0006195 | purine nucleotide catabolic process | 1.989073e-3 |
GO:0048554 | positive regulation of metalloenzyme activity | 2.131773e-3 |
GO:0045212 | neurotransmitter receptor biosynthetic process | 2.131773e-3 |
GO:0006888 | ER to Golgi vesicle-mediated transport | 2.173715e-3 |
GO:0044248 | cellular catabolic process | 2.250043e-3 |
GO:0042177 | negative regulation of protein catabolic process | 2.253395e-3 |
GO:0043044 | ATP-dependent chromatin remodeling | 2.257464e-3 |
GO:0001765 | membrane raft assembly | 2.307129e-3 |
GO:0042384 | cilium assembly | 2.321193e-3 |
GO:0031915 | positive regulation of synaptic plasticity | 2.352712e-3 |
GO:0021544 | subpallium development | 2.515695e-3 |
GO:0061349 | planar cell polarity pathway involved in cardiac right atrium morphogenesis | 2.534439e-3 |
GO:0061350 | planar cell polarity pathway involved in cardiac muscle tissue morphogenesis | 2.534439e-3 |
GO:0061354 | planar cell polarity pathway involved in pericardium morphogenesis | 2.534439e-3 |
GO:0061348 | planar cell polarity pathway involved in ventricular septum morphogenesis | 2.534439e-3 |
GO:0000432 | positive regulation of transcription from RNA polymerase II promoter by glucose | 2.534439e-3 |
GO:0061347 | planar cell polarity pathway involved in outflow tract morphogenesis | 2.534439e-3 |
GO:0009957 | epidermal cell fate specification | 2.534439e-3 |
GO:0060210 | metestrus | 2.534439e-3 |
GO:0030719 | P granule organization | 2.554317e-3 |
GO:0002358 | B cell homeostatic proliferation | 2.554317e-3 |
GO:0042744 | hydrogen peroxide catabolic process | 2.560245e-3 |
GO:0051187 | cofactor catabolic process | 2.584804e-3 |
GO:0060684 | epithelial-mesenchymal cell signaling | 2.598728e-3 |
GO:0007603 | phototransduction, visible light | 2.618092e-3 |
GO:0060488 | orthogonal dichotomous subdivision of terminal units involved in lung branching morphogenesis | 2.664976e-3 |
GO:0060489 | planar dichotomous subdivision of terminal units involved in lung branching morphogenesis | 2.664976e-3 |
GO:0060490 | lateral sprouting involved in lung morphogenesis | 2.664976e-3 |
GO:0048105 | establishment of body hair planar orientation | 2.664976e-3 |
GO:0006545 | glycine biosynthetic process | 2.664976e-3 |
GO:0000720 | pyrimidine dimer repair by nucleotide-excision repair | 2.664976e-3 |
GO:0009199 | ribonucleoside triphosphate metabolic process | 2.702437e-3 |
GO:0050685 | positive regulation of mRNA processing | 2.709442e-3 |
GO:0009150 | purine ribonucleotide metabolic process | 2.748703e-3 |
GO:0010467 | gene expression | 2.754108e-3 |
GO:0033600 | negative regulation of mammary gland epithelial cell proliferation | 2.847346e-3 |
GO:0009896 | positive regulation of catabolic process | 2.881655e-3 |
GO:0006409 | tRNA export from nucleus | 2.931392e-3 |
GO:0002638 | negative regulation of immunoglobulin production | 2.931392e-3 |
GO:0001811 | negative regulation of type I hypersensitivity | 2.931392e-3 |
GO:0001732 | formation of translation initiation complex | 2.960246e-3 |
GO:0045064 | T-helper 2 cell differentiation | 2.996868e-3 |
GO:0071894 | histone H2B conserved C-terminal lysine ubiquitination | 2.996868e-3 |
GO:0046700 | heterocycle catabolic process | 2.998419e-3 |
GO:0010868 | negative regulation of triglyceride biosynthetic process | 3.023929e-3 |
GO:0061056 | sclerotome development | 3.150278e-3 |
GO:2000049 | positive regulation of cell-cell adhesion mediated by cadherin | 3.159933e-3 |
GO:0006681 | galactosylceramide metabolic process | 3.159933e-3 |
GO:0014003 | oligodendrocyte development | 3.220824e-3 |
GO:0045333 | cellular respiration | 3.275573e-3 |
GO:0021533 | cell differentiation in hindbrain | 3.341862e-3 |
GO:0032691 | negative regulation of interleukin-1 beta production | 3.345342e-3 |
GO:0051639 | actin filament network formation | 3.363398e-3 |
GO:0009205 | purine ribonucleoside triphosphate metabolic process | 3.440501e-3 |
GO:0055062 | phosphate ion homeostasis | 3.537603e-3 |
GO:0032469 | endoplasmic reticulum calcium ion homeostasis | 3.580304e-3 |
GO:0046835 | carbohydrate phosphorylation | 3.594076e-3 |
GO:0032682 | negative regulation of chemokine production | 3.648969e-3 |
GO:0051586 | positive regulation of dopamine uptake | 3.648969e-3 |
GO:0043374 | CD8-positive, alpha-beta T cell differentiation | 3.699462e-3 |
GO:0043486 | histone exchange | 3.766596e-3 |
GO:0060334 | regulation of interferon-gamma-mediated signaling pathway | 3.771565e-3 |
GO:0051561 | elevation of mitochondrial calcium ion concentration | 3.889103e-3 |
GO:0006099 | tricarboxylic acid cycle | 3.899998e-3 |
GO:0034655 | nucleobase-containing compound catabolic process | 3.901158e-3 |
GO:0060686 | negative regulation of prostatic bud formation | 3.907079e-3 |
GO:0051248 | negative regulation of protein metabolic process | 3.911034e-3 |
GO:0042941 | D-alanine transport | 3.913947e-3 |
GO:0046605 | regulation of centrosome cycle | 3.968049e-3 |
GO:0042158 | lipoprotein biosynthetic process | 3.999776e-3 |
GO:0009166 | nucleotide catabolic process | 4.051441e-3 |
GO:0006200 | ATP catabolic process | 4.132988e-3 |
GO:0033084 | regulation of immature T cell proliferation in thymus | 4.150797e-3 |
GO:0009259 | ribonucleotide metabolic process | 4.187410e-3 |
GO:2000795 | negative regulation of epithelial cell proliferation involved in lung morphogenesis | 4.208073e-3 |
GO:2000791 | negative regulation of mesenchymal cell proliferation involved in lung development | 4.208073e-3 |
GO:0050711 | negative regulation of interleukin-1 secretion | 4.208073e-3 |
GO:0021740 | principal sensory nucleus of trigeminal nerve development | 4.208073e-3 |
GO:0061141 | lung ciliated cell differentiation | 4.208073e-3 |
GO:0042256 | mature ribosome assembly | 4.357735e-3 |
GO:0007129 | synapsis | 4.399453e-3 |
GO:0018279 | protein N-linked glycosylation via asparagine | 4.421441e-3 |
GO:0071157 | negative regulation of cell cycle arrest | 4.540236e-3 |
GO:0006638 | neutral lipid metabolic process | 4.596756e-3 |
GO:0008629 | induction of apoptosis by intracellular signals | 4.598755e-3 |
GO:0010623 | developmental programmed cell death | 4.655313e-3 |
GO:0034619 | cellular chaperone-mediated protein complex assembly | 4.697527e-3 |
GO:0046038 | GMP catabolic process | 4.708414e-3 |
GO:0046602 | regulation of mitotic centrosome separation | 4.708414e-3 |
GO:0045799 | positive regulation of chromatin assembly or disassembly | 4.708414e-3 |
GO:0060217 | hemangioblast cell differentiation | 4.708414e-3 |
GO:0006178 | guanine salvage | 4.708414e-3 |
GO:0032263 | GMP salvage | 4.708414e-3 |
GO:0032264 | IMP salvage | 4.708414e-3 |
GO:0045806 | negative regulation of endocytosis | 4.722671e-3 |
GO:0006414 | translational elongation | 4.722671e-3 |
GO:0061013 | regulation of mRNA catabolic process | 4.761208e-3 |
GO:0048261 | negative regulation of receptor-mediated endocytosis | 4.767236e-3 |
GO:0042532 | negative regulation of tyrosine phosphorylation of STAT protein | 4.775797e-3 |
GO:0060067 | cervix development | 4.775836e-3 |
GO:0010248 | establishment or maintenance of transmembrane electrochemical gradient | 4.775836e-3 |
GO:0090267 | positive regulation of mitotic cell cycle spindle assembly checkpoint | 4.886168e-3 |
GO:0061025 | membrane fusion | 4.963991e-3 |
GO:0021542 | dentate gyrus development | 5.075753e-3 |
GO:0009886 | post-embryonic morphogenesis | 5.098835e-3 |
GO:0046426 | negative regulation of JAK-STAT cascade | 5.113638e-3 |
GO:0045415 | negative regulation of interleukin-8 biosynthetic process | 5.135830e-3 |
GO:0051771 | negative regulation of nitric-oxide synthase biosynthetic process | 5.135830e-3 |
GO:0051454 | intracellular pH elevation | 5.135830e-3 |
GO:0035786 | protein complex oligomerization | 5.135830e-3 |
GO:0002642 | positive regulation of immunoglobulin biosynthetic process | 5.135830e-3 |
GO:0016139 | glycoside catabolic process | 5.135830e-3 |
GO:0042996 | regulation of Golgi to plasma membrane protein transport | 5.135830e-3 |
GO:0048368 | lateral mesoderm development | 5.288834e-3 |
GO:0006944 | cellular membrane fusion | 5.298206e-3 |
GO:0031119 | tRNA pseudouridine synthesis | 5.390142e-3 |
GO:0006139 | nucleobase-containing compound metabolic process | 5.420226e-3 |
GO:0051571 | positive regulation of histone H3-K4 methylation | 5.563295e-3 |
GO:0051299 | centrosome separation | 5.563295e-3 |
GO:0071243 | cellular response to arsenic-containing substance | 5.594771e-3 |
GO:0002739 | regulation of cytokine secretion involved in immune response | 5.635303e-3 |
GO:0001840 | neural plate development | 5.664110e-3 |
GO:2000272 | negative regulation of receptor activity | 5.728034e-3 |
GO:0016090 | prenol metabolic process | 5.740207e-3 |
GO:0042699 | follicle-stimulating hormone signaling pathway | 5.795766e-3 |
GO:0051204 | protein insertion into mitochondrial membrane | 5.819823e-3 |
GO:0030902 | hindbrain development | 6.089188e-3 |
GO:0033194 | response to hydroperoxide | 6.200160e-3 |
GO:0070192 | chromosome organization involved in meiosis | 6.225922e-3 |
GO:0043372 | positive regulation of CD4-positive, alpha-beta T cell differentiation | 6.225922e-3 |
GO:0061014 | positive regulation of mRNA catabolic process | 6.386458e-3 |
GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis | 6.386458e-3 |
GO:0021754 | facial nucleus development | 6.413951e-3 |
GO:0003221 | right ventricular cardiac muscle tissue morphogenesis | 6.413951e-3 |
GO:0048857 | neural nucleus development | 6.433958e-3 |
GO:0031124 | mRNA 3'-end processing | 6.481379e-3 |
GO:0060056 | mammary gland involution | 6.532683e-3 |
GO:0006818 | hydrogen transport | 6.648422e-3 |
GO:0032692 | negative regulation of interleukin-1 production | 6.769631e-3 |
GO:0019217 | regulation of fatty acid metabolic process | 6.838140e-3 |
GO:0072655 | establishment of protein localization in mitochondrion | 6.884420e-3 |
GO:0043170 | macromolecule metabolic process | 6.910393e-3 |
GO:2000210 | positive regulation of anoikis | 6.977700e-3 |
GO:0060599 | lateral sprouting involved in mammary gland duct morphogenesis | 6.977700e-3 |
GO:0046785 | microtubule polymerization | 6.977700e-3 |
GO:0002741 | positive regulation of cytokine secretion involved in immune response | 6.977700e-3 |
GO:0045040 | protein import into mitochondrial outer membrane | 6.977700e-3 |
GO:0009083 | branched chain family amino acid catabolic process | 6.983291e-3 |
GO:0060287 | epithelial cilium movement involved in determination of left/right asymmetry | 7.006899e-3 |
GO:0006449 | regulation of translational termination | 7.006899e-3 |
GO:0001844 | protein insertion into mitochondrial membrane involved in induction of apoptosis | 7.006899e-3 |
GO:0090304 | nucleic acid metabolic process | 7.013531e-3 |
GO:0072560 | type B pancreatic cell maturation | 7.014072e-3 |
GO:0046373 | L-arabinose metabolic process | 7.014072e-3 |
GO:0010845 | positive regulation of reciprocal meiotic recombination | 7.014072e-3 |
GO:0034551 | mitochondrial respiratory chain complex III assembly | 7.014072e-3 |
GO:0071034 | CUT catabolic process | 7.046887e-3 |
GO:0031508 | centromeric heterochromatin formation | 7.046887e-3 |
GO:0018206 | peptidyl-methionine modification | 7.046887e-3 |
GO:0072017 | distal tubule development | 7.074342e-3 |
GO:0033083 | regulation of immature T cell proliferation | 7.120743e-3 |
GO:0009996 | negative regulation of cell fate specification | 7.120743e-3 |
GO:0007017 | microtubule-based process | 7.124368e-3 |
GO:0009144 | purine nucleoside triphosphate metabolic process | 7.174904e-3 |
GO:0031109 | microtubule polymerization or depolymerization | 7.190386e-3 |
GO:0043586 | tongue development | 7.245708e-3 |
GO:0044241 | lipid digestion | 7.315357e-3 |
GO:0032731 | positive regulation of interleukin-1 beta production | 7.352005e-3 |
GO:0035176 | social behavior | 7.355858e-3 |
GO:0048259 | regulation of receptor-mediated endocytosis | 7.483696e-3 |
GO:0050684 | regulation of mRNA processing | 7.557099e-3 |
GO:0006924 | activation-induced cell death of T cells | 7.687295e-3 |
GO:0044270 | cellular nitrogen compound catabolic process | 7.761296e-3 |
GO:0008635 | activation of caspase activity by cytochrome c | 7.762672e-3 |
GO:0000738 | DNA catabolic process, exonucleolytic | 7.840736e-3 |
GO:0006030 | chitin metabolic process | 7.840736e-3 |
GO:0001738 | morphogenesis of a polarized epithelium | 8.018299e-3 |
GO:0043367 | CD4-positive, alpha-beta T cell differentiation | 8.080052e-3 |
GO:0015914 | phospholipid transport | 8.135971e-3 |
GO:0032886 | regulation of microtubule-based process | 8.142778e-3 |
GO:0034641 | cellular nitrogen compound metabolic process | 8.157123e-3 |
GO:0015992 | proton transport | 8.212700e-3 |
GO:0018205 | peptidyl-lysine modification | 8.300145e-3 |
GO:0008354 | germ cell migration | 8.317320e-3 |
GO:0008544 | epidermis development | 8.379012e-3 |
GO:0033036 | macromolecule localization | 8.440411e-3 |
GO:0072044 | collecting duct development | 8.536259e-3 |
GO:0006639 | acylglycerol metabolic process | 8.559420e-3 |
GO:0060685 | regulation of prostatic bud formation | 8.610882e-3 |
GO:0040037 | negative regulation of fibroblast growth factor receptor signaling pathway | 8.629012e-3 |
GO:0010565 | regulation of cellular ketone metabolic process | 8.710454e-3 |
GO:0060285 | ciliary cell motility | 8.715906e-3 |
GO:0030046 | parallel actin filament bundle assembly | 8.715906e-3 |
GO:0007602 | phototransduction | 8.722164e-3 |
GO:0021766 | hippocampus development | 8.727209e-3 |
GO:0043507 | positive regulation of JUN kinase activity | 8.895830e-3 |
GO:0050996 | positive regulation of lipid catabolic process | 8.908844e-3 |
GO:0046108 | uridine metabolic process | 8.923170e-3 |
GO:0090138 | regulation of actin cytoskeleton organization by cell-cell adhesion | 9.040969e-3 |
GO:0070508 | cholesterol import | 9.139750e-3 |
GO:0031398 | positive regulation of protein ubiquitination | 9.315758e-3 |
GO:0046963 | 3'-phosphoadenosine 5'-phosphosulfate transport | 9.423287e-3 |
GO:0001514 | selenocysteine incorporation | 9.423287e-3 |
GO:0010595 | positive regulation of endothelial cell migration | 9.551776e-3 |
GO:0032784 | regulation of transcription elongation, DNA-dependent | 9.614566e-3 |
GO:0003347 | epicardial cell to mesenchymal cell transition | 9.774754e-3 |
GO:0006497 | protein lipidation | 9.825028e-3 |
GO:0035385 | Roundabout signaling pathway | 9.892302e-3 |
GO:0000083 | regulation of transcription involved in G1/S phase of mitotic cell cycle | 9.892302e-3 |
GO:0003142 | cardiogenic plate morphogenesis | 1.000503e-2 |
GO:0060807 | regulation of transcription from RNA polymerase II promoter involved in definitive endodermal cell fate specification | 1.000503e-2 |
GO:0001828 | inner cell mass cellular morphogenesis | 1.000503e-2 |
GO:0043506 | regulation of JUN kinase activity | 1.006711e-2 |
GO:0007175 | negative regulation of epidermal growth factor-activated receptor activity | 1.015446e-2 |
GO:0051103 | DNA ligation involved in DNA repair | 1.028467e-2 |
GO:0071951 | conversion of methionyl-tRNA to N-formyl-methionyl-tRNA | 1.039350e-2 |
GO:0060847 | endothelial cell fate specification | 1.039350e-2 |
GO:0035871 | protein K11-linked deubiquitination | 1.039350e-2 |
GO:0032375 | negative regulation of cholesterol transport | 1.043350e-2 |
GO:0021988 | olfactory lobe development | 1.046420e-2 |
GO:0043201 | response to leucine | 1.049318e-2 |
GO:0072321 | chaperone-mediated protein transport | 1.049318e-2 |
GO:0055014 | atrial cardiac muscle cell development | 1.071787e-2 |
GO:0032732 | positive regulation of interleukin-1 production | 1.091588e-2 |
GO:0009056 | catabolic process | 1.120121e-2 |
GO:0045948 | positive regulation of translational initiation | 1.125920e-2 |
GO:0043543 | protein acylation | 1.145895e-2 |
GO:0050919 | negative chemotaxis | 1.153524e-2 |
GO:0040020 | regulation of meiosis | 1.153524e-2 |